Table II.

Correlation between the miR-34b/c rs4938723 T>C genotypes and clinical characteristics of breast cancer patients.

	miR-34b/c rs4938723 T>C genotypes
Variables	TT	CT	CC	P-value
Age, years				0.535
≤50	63	68	14
>50	56	46	9
Mean BMI ± SD, kg/m2	25.8±3.2	25.6±3.3	26.4±2.5	0.489
Tumor size, cm				0.453
≤2	44	34	9
>2	72	76	13
Lymph node metastasis status, n				0.848
Yes	34	30	5
No	44	43	9
Grade, n				0.028
I	17	23	5
II	74	56	7
III+IV	16	21	8
Stage, n				0.941
I	21	20	2
II	44	44	10
III	34	28	7
IV	19	18	3
Histology, n				0.890
Ductal carcinoma	85	72	16
Other	29	36	7
Estrogen receptor, n				0.004
Positive	65	67	21
Negative	46	35	1
Progesterone receptor, n				0.007
Positive	58	72	16
Negative	53	28	6
HER2, n				0.031
Positive	56	64	7
Negative	61	45	16

BMI, body mass index; SD, standard deviation; HER2, human epidermal growth factor receptor 2.